RxDoctor Payments Data

Deborah Aultman

Physician Assistant · Stanton, MINPI 1831134394

Payments from drug & device makers

$3,795in general payments, 2019–2025

Across 198 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$520
  • Novo Nordisk$330
  • Lilly USA, LLC$319
  • Xeris Pharmaceuticals, Inc.$315
  • Novartis$269
  • Pfizer$204
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$3,71298%
  • Education$832%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,795 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide35$39,460
OzempicSemaglutide29$32,620
EliquisApixaban25$24,599
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$23,467
TrulicityDulaglutide14$20,087
MyrbetriqMirabegron22$18,631
XareltoRivaroxaban15$15,114
JardianceEmpagliflozin14$14,492
Atorvastatin Calcium192$2,445
Levothyroxine Sodium175$1,742
Albuterol Sulfate HfaAlbuterol Sulfate42$1,652
Rosuvastatin Calcium65$1,377
Omeprazole95$1,370
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen46$1,176
Losartan Potassium73$1,135

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$319$59,54749 claims
Novo NordiskOzempic$330$32,62029 claims
PfizerEliquis$204$24,59925 claims
GSKTrelegy Ellipta$69$23,46725 claims
Astellas Pharma US IncMyrbetriq$203$18,63122 claims
Johnson & JohnsonXarelto$186$15,11415 claims
Boehringer IngelheimJardiance$99$14,49214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Stanton

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →